---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-078902"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T05:58:10.272649+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Oramed posts investor presentation; no new material financial or operational data disclosed

## Summary
- Filed an investor presentation dated December 12, 2022 on its website.
- Presentation titled 'Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations' provides a general overview.
- No specific financial updates, guidance changes, or pipeline milestones were included in the filing.

## SEC filing metadata
- accession: 0001213900-22-078902
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/0001213900-22-078902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/ea169983-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-078902
- JSON: https://secwatch.observer/filing/0001213900-22-078902.json
- Plain text: https://secwatch.observer/filing/0001213900-22-078902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.